These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 17325139)
21. Prevalence of age-related maculopathy at two points in time in an elderly British population. Dickinson AJ; Sparrow JM; Duke AM; Thompson JR; Gibson JM; Rosenthal AR Eye (Lond); 1997; 11 ( Pt 3)():301-14. PubMed ID: 9373467 [TBL] [Abstract][Full Text] [Related]
22. 14-year incidence, progression, and visual morbidity of age-related maculopathy: the Copenhagen City Eye Study. Buch H; Nielsen NV; Vinding T; Jensen GB; Prause JU; la Cour M Ophthalmology; 2005 May; 112(5):787-98. PubMed ID: 15878058 [TBL] [Abstract][Full Text] [Related]
23. Risk factors for age-related maculopathy in a 14-year follow-up study: the Copenhagen City Eye Study. Buch H; Vinding T; la Cour M; Jensen GB; Prause JU; Nielsen NV Acta Ophthalmol Scand; 2005 Aug; 83(4):409-18. PubMed ID: 16029262 [TBL] [Abstract][Full Text] [Related]
24. Prevalence of age-related macular degeneration in a population-based sample of Hispanic people in Arizona: Proyecto VER. Muñoz B; Klein R; Rodriguez J; Snyder R; West SK Arch Ophthalmol; 2005 Nov; 123(11):1575-80. PubMed ID: 16286621 [TBL] [Abstract][Full Text] [Related]
25. Statins and the long-term risk of incident age-related macular degeneration: the Blue Mountains Eye Study. Tan JS; Mitchell P; Rochtchina E; Wang JJ Am J Ophthalmol; 2007 Apr; 143(4):685-7. PubMed ID: 17386278 [TBL] [Abstract][Full Text] [Related]
26. Prevalence of age-related macular degeneration in Greece: the Thessaloniki Eye Study. Topouzis F; Coleman AL; Harris A; Anastasopoulos E; Yu F; Koskosas A; Pappas T; Mavroudis L; Wilson MR Am J Ophthalmol; 2006 Dec; 142(6):1076-9. PubMed ID: 17157601 [TBL] [Abstract][Full Text] [Related]
27. Incidence and progression rates of age-related maculopathy: the Rotterdam Study. Klaver CC; Assink JJ; van Leeuwen R; Wolfs RC; Vingerling JR; Stijnen T; Hofman A; de Jong PT Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2237-41. PubMed ID: 11527936 [TBL] [Abstract][Full Text] [Related]
28. Cigarette smoking and age-related macular degeneration in the EUREYE Study. Chakravarthy U; Augood C; Bentham GC; de Jong PT; Rahu M; Seland J; Soubrane G; Tomazzoli L; Topouzis F; Vingerling JR; Vioque J; Young IS; Fletcher AE Ophthalmology; 2007 Jun; 114(6):1157-63. PubMed ID: 17337063 [TBL] [Abstract][Full Text] [Related]
29. Australian prospective study of cataract surgery and age-related macular degeneration: rationale and methodology. Cugati S; de Loryn T; Pham T; Arnold J; Mitchell P; Wang JJ Ophthalmic Epidemiol; 2007; 14(6):408-14. PubMed ID: 18161615 [TBL] [Abstract][Full Text] [Related]
30. Risk factors for five-year incident age-related macular degeneration: the Reykjavik Eye Study. Arnarsson A; Sverrisson T; Stefánsson E; Sigurdsson H; Sasaki H; Sasaki K; Jonasson F Am J Ophthalmol; 2006 Sep; 142(3):419-28. PubMed ID: 16935586 [TBL] [Abstract][Full Text] [Related]
31. Pattern of age-related maculopathy in the macular area. The Beaver Dam Eye Study. Wang Q; Chappell RJ; Klein R; Eisner A; Klein BE; Jensen SC; Moss SE Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2234-42. PubMed ID: 8843910 [TBL] [Abstract][Full Text] [Related]
32. Depressive symptoms and age-related macular degeneration in older people: the cardiovascular health study. Sun C; Tikellis G; Klein R; Steffens DC; Larsen EK; Wong TY Ophthalmic Epidemiol; 2007; 14(3):127-33. PubMed ID: 17613847 [TBL] [Abstract][Full Text] [Related]
33. Prevalence of diabetic retinopathy in rural China: the Handan Eye Study. Wang FH; Liang YB; Zhang F; Wang JJ; Wei WB; Tao QS; Sun LP; Friedman DS; Wang NL; Wong TY Ophthalmology; 2009 Mar; 116(3):461-7. PubMed ID: 19168222 [TBL] [Abstract][Full Text] [Related]
34. The epidemiology of age-related macular degeneration in the Indian subcontinent. Woo JH; Sanjay S; Au Eong KG Acta Ophthalmol; 2009 May; 87(3):262-9. PubMed ID: 19016663 [TBL] [Abstract][Full Text] [Related]
35. Prevalence of primary angle-closure disease in an urban south Indian population and comparison with a rural population. The Chennai Glaucoma Study. Vijaya L; George R; Arvind H; Baskaran M; Ve Ramesh S; Raju P; Kumaramanickavel G; McCarty C Ophthalmology; 2008 Apr; 115(4):655-660.e1. PubMed ID: 17869343 [TBL] [Abstract][Full Text] [Related]
36. The prevalence of age-related maculopathy: the visual impairment project. VanNewkirk MR; Nanjan MB; Wang JJ; Mitchell P; Taylor HR; McCarty CA Ophthalmology; 2000 Aug; 107(8):1593-600. PubMed ID: 10919916 [TBL] [Abstract][Full Text] [Related]
37. Risk factors for choroidal neovascularization and geographic atrophy in the complications of age-related macular degeneration prevention trial. Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group Ophthalmology; 2008 Sep; 115(9):1474-9, 1479.e1-6. PubMed ID: 18502512 [TBL] [Abstract][Full Text] [Related]
38. Sex steroids and age-related macular degeneration in older French women: the POLA study. Defay R; Pinchinat S; Lumbroso S; Sutan C; Delcourt C; Ann Epidemiol; 2004 Mar; 14(3):202-8. PubMed ID: 15036224 [TBL] [Abstract][Full Text] [Related]
39. Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE). Augood CA; Vingerling JR; de Jong PT; Chakravarthy U; Seland J; Soubrane G; Tomazzoli L; Topouzis F; Bentham G; Rahu M; Vioque J; Young IS; Fletcher AE Arch Ophthalmol; 2006 Apr; 124(4):529-35. PubMed ID: 16606879 [TBL] [Abstract][Full Text] [Related]
40. Prevalence of age-related macular degeneration in a large European cohort: results from the population-based Gutenberg Health Study. Korb CA; Kottler UB; Wolfram C; Hoehn R; Schulz A; Zwiener I; Wild PS; Pfeiffer N; Mirshahi A Graefes Arch Clin Exp Ophthalmol; 2014 Sep; 252(9):1403-11. PubMed ID: 24566902 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]